LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method

被引:99
作者
Bhutani, Hemant
Singh, Saranjit
Vir, Sanjay
Bhutani, K. K.
Kumar, Raj
Chakraborti, Asit K.
Jindal, K. C.
机构
[1] NIPER, Dept Pharmaceut Anal, SAS Nagar 160062, Punjab, India
[2] NIPER, Dept Nat Prod, SAS Nagar 160062, Punjab, India
[3] NIPER, Dept Med Chem, SAS Nagar 160062, Punjab, India
[4] MS Pancea Biotec Ltd, Lairu 140501, Punjab, India
关键词
isoniazid; stress testing; stability-indicating assay; validation; LC; LC-MS; degradation products;
D O I
10.1016/j.jpba.2006.10.013
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Isoniazid was subjected to different ICH prescribed stress conditions of thermal stress, hydrolysis, oxidation and photolysis. The drug was stable to dry heat (50 and 60 degrees C). It showed extensive decomposition under hydrolytic conditions, while it was only moderately sensitive to oxidation stress. The solid drug turned intense yellow on exposure to light under accelerated conditions of temperature (40 degrees C) and humidity (75% RH). In total, three major degradation products were detected by LC. For establishment of stability-indicating assay, the reaction solutions in which different degradation products were formed were mixed, and the separation was optimized by varying the LC conditions. An acceptable separation was achieved using, a C-18 column and a mobile phase comprising of water: acetonitrile (96:4, v/v), with flow rate and detection wavelength being 0.5 ml min(-1) and 254 nm, respectively. The degradation products appeared at relative retention times (RRT) of 0.71, 1.34 and 4.22. The validation studies established a linear response of the drug at concentrations between 50 and 1000 mu g ml(-1). The mean values (+/- R.S.D.) of slope, intercept and correlation coefficient were 35,199 (+/- 0.88), 114,310 (+/- 4.70) and 0.9998 (+/- 0.01), respectively. The mean R.S.D. values for intra- and inter-day precision were 0.24 and 0.90, respectively. The recovery of the drug ranged between 99.42 and 100.58%, when it was spiked to a mixture of solutions in which sufficient degradation was observed. The specificity was established through peak purity testing using a photodiode array detector. The method worked well on application to marketed formulation of isoniazid, and a fixed-dose combination containing isoniazid and ethambutol HCl. It was even extendable to LC-MS studies, which were carried out to identify the three degradation products. The m/z values of the peaks at RRT 0.71 and RRT 1.34 matched with isonicotinic acid and isonicotinamide, respectively. The product appearing at RRT 4.22 was isolated using preparative LC-MS, and turned out to be a yellow compound that was identified as isonicotinic acid N'-(pyridyl-4-carbonyl)-hydrazide based on mass. FTIR and H-1/C-13 NMR spectral data. The same was indicated to be responsible for discolouration of isoniazid bulk drug substance and formulations. which is a familiar problem. The mechanism of formation of the said compound is outlined. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1213 / 1220
页数:8
相关论文
共 22 条
[1]  
[Anonymous], [No title captured]
[2]  
[Anonymous], 1996, INT C HARMONISATION
[3]   The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stability-indicating assay [J].
Bakshi, M ;
Singh, B ;
Singh, A ;
Singh, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (5-6) :891-897
[4]   Drug-drug interaction studies on first-line anti-tuberculosis drugs [J].
Bhutani, H ;
Singh, S ;
Jindal, KC .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (04) :517-524
[5]   Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs [J].
Bhutani, H ;
Singh, S ;
Jindal, KC ;
Chakraborti, AK .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (05) :892-899
[6]  
BREWER GA, 1976, ANAL PROFILES DRUG S, P184
[7]   Stability of isoniazid in isoniazid syrup: formation of hydrazine [J].
Carlin, A ;
Gregory, N ;
Simmons, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (4-5) :885-890
[8]  
CARRY FA, 2000, ADV ORG CHEM, P727
[9]   PHOTOLYSIS OF ISONIAZID [J].
CHIANG, HC ;
LIN, LJ .
JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 1978, 25 (03) :125-130
[10]  
COLWELL CA, 1956, AM REV TUBERC PULM, V73, P892